HistCite - Trojanowski w/citing papers

Add FileX ?

Use wildcard '*' to add more than one file at a time. For example, if you have file1, file2, etc. all in the same folder or directory; first, locate one of the files with the [Browse...] button. Then alter the file path in the box above to include '*' character (eg. file*). Wildcard '?' to blanket only one character works too.
Note: In Windows you can select multiple files and "drag and drop" them onto HistCite icon or shortcut. The program would start and load those files.

#	Date / Author / Journal	LCS	GCS	LCR	CR
1701	15345 Forman MS, Lal D, Zhang B, Dabir DV, Swanson E, et al. Transgenic mouse model of tau pathology in astrocytes leading to nervous system degeneration JOURNAL OF NEUROSCIENCE. 2005 APR 6; 25 (14): 3539-3550	36	36	34	56
1702	16079 Taniguchi T, Doe N, Matsuyama S, Kitamura Y, Mori H, et al. Transgenic mice expressing mutant (N279K) human tau show mutation dependent cognitive deficits without neurofibrillary tangle formation FEBS LETTERS. 2005 OCT 24; 579 (25): 5704-5712	11	17	34	58
1703	16290 Zhang C, Saatman KE, Royo NC, Soltesz KM, Millard M, et al. Delayed transplantation of human neurons following brain injury in rats: A long-term graft survival and behavior study JOURNAL OF NEUROTRAUMA. 2005 DEC; 22 (12): 1456-1474	11	11	34	70
1704	16333 Dermaut B, Kumar-Singh S, Rademakers R, Theuns J, Cruts M, et al. Tau is central in the genetic Alzheimer-frontotemporal dementia spectrum TRENDS IN GENETICS. 2005 DEC; 21 (12): 664-672	17	26	34	85
1705	16461 Kurz MW, Schlitter AM, Larsen JP, Ballard C, Aarsland D Familial occurrence of dementia and parkinsonism - A systematic review DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2006; 22 (4): 288-295	5	7	34	67
1706	16887 Sarkar C, Deb P, Sharma MC Medulloblastomas: New directions in risk stratification NEUROLOGY INDIA. 2006 MAR; 54 (1): 16-23	2	9	34	130
1707	16901 Zhou WB, Zhu M, Wilson MA, Petsko GA, Fink AL The oxidation state of DJ-1 regulates its chaperone activity toward alpha-synuclein JOURNAL OF MOLECULAR BIOLOGY. 2006 MAR 3; 356 (4): 1036-1048	37	99	34	59
1708	16966 Chaudhuri TK, Paul S Protein-misfolding diseases and chaperone-based therapeutic approaches FEBS JOURNAL. 2006 APR; 273 (7): 1331-1349	14	70	34	145
1709	17085 Motil J, Chan WKH, Dubey M, Chaudhury P, Pimenta A, et al. Dynein mediates retrograde neurofilament transport within axons and anterograde delivery of NFs from perikarya into axons: Regulation by multiple phosphorylation events CELL MOTILITY AND THE CYTOSKELETON. 2006 MAY; 63 (5): 266-286	8	20	34	84
1710	17151 Jabbour-Wadih T, Alonso-Navarro H, Ayuso-Peralta L, Jimenez-Jimenez FJ The neurochemistry and neuropharmacology of diffuse Lewy body disease REVISTA DE NEUROLOGIA. 2006 MAY 1; 42 (9): 549-555	0	0	34	109
#	Date / Author / Journal	LCS	GCS	LCR	CR
1711	17158 Llado A, Gaig C, Molinuevo JL Genetics of prevalent neurodegenerative disorders MEDICINA CLINICA. 2006 MAY 6; 126 (17): 662-670	0	0	34	104
1712	17295 Golovko MY, Rosenberger TA, Faergeman NJ, Feddersen S, Cole NB, et al. Acyl-CoA synthetase activity links wild-type but not mutant alpha- synuclein to brain arachidonate metabolism BIOCHEMISTRY. 2006 JUN 6; 45 (22): 6956-6966	14	22	34	94
1713	17551 Jellinger KA, Attems J Does striatal pathology distinguish Parkinson disease with dementia and dementia with Lewy bodies? ACTA NEUROPATHOLOGICA. 2006 SEP; 112 (3): 253-260	29	30	34	64
1714	17661 Vandebroek T, Terwel D, Vanhelmont T, Gysemans M, Van Haesendonck C, et al. Microtubule binding and clustering of human Tau-4R and Tau-P301L proteins isolated from yeast deficient in orthologues of glycogen synthase kinase-3 beta or cdk5 JOURNAL OF BIOLOGICAL CHEMISTRY. 2006 SEP 1; 281 (35): 25388-25397	10	13	34	48
1715	17673 Karsten SL, Sang TK, Gehman LT, Chatterjee S, Liu JK, et al. A genomic screen for modifiers of tauopathy identifies puromycin- sensitive aminopeptidase as an inhibitor of tau-induced neurodegeneration NEURON. 2006 SEP 7; 51 (5): 549-560	30	42	34	69
1716	17712 Murakami T, Paitel E, Kawarabayashi T, Ikeda M, Chishti MA, et al. Cortical neuronal and glial pathology in TgTau(P301L) transgenic mice - Neuronal degeneration, memory disturbance, and phenotypic variation AMERICAN JOURNAL OF PATHOLOGY. 2006 OCT; 169 (4): 1365-1375	16	17	34	46
1717	17926 Caselli RJ, Beach TG, Yaari R, Reiman EM Alzheimer's disease a century later JOURNAL OF CLINICAL PSYCHIATRY. 2006 NOV; 67 (11): 1784-1800	5	35	34	199
1718	17959 Colapinto M, Mila S, Giraudo S, Stefanazzi P, Molteni M, et al. alpha-synuclein protects SH-SY5Y cells from dopamine toxicity BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2006 NOV 3; 349 (4): 1294-1300	11	15	34	59
1719	18231 Krewski D, Yokel RA, Nieboer E, Borchelt D, Cohen J, et al. Human health risk assessment for aluminium, aluminium oxide, and aluminium hydroxide JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART B-CRITICAL REVIEWS. 2007; 10: 1-269	3	18	34	1515
1720	18260 Schmidt E, Seifert M, Baumeister R Caenorhabditis elegans as a model system for Parkinson's disease NEURODEGENERATIVE DISEASES. 2007; 4 (2-3): 199-217	3	8	34	110
#	Date / Author / Journal	LCS	GCS	LCR	CR
1721	18336 Kolomeets NS The pathology of the hippocampus in schizophrenia ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA. 2007; 107 (12): 103-114	0	0	34	166
1722	18365 Frid P, Anisimov SV, Popovic N Congo red and protein aggregation in neurodegenerative diseases BRAIN RESEARCH REVIEWS. 2007 JAN; 53 (1): 135-160	12	50	34	214
1723	18530 Liu LL, Franz KJ Phosphorylation-dependent metal binding by alpha-synuclein peptide fragments JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY. 2007 FEB; 12 (2): 234-247	5	12	34	76
1724	18831 Golovko MY, Rosenberger TA, Feddersen S, Faergeman NJ, Murphy EJ alpha-Synuclein gene ablation increases docosahexaenoic acid incorporation and turnover in brain phospholipids JOURNAL OF NEUROCHEMISTRY. 2007 APR; 101 (1): 201-211	11	20	34	77
1725	18929 Dufty BM, Warner LR, Hou ST, Jiang SX, Gomez-Isla T, et al. Calpain-cleavage of alpha-synuclein - Connecting proteolytic processing to disease-linked aggregation AMERICAN JOURNAL OF PATHOLOGY. 2007 MAY; 170 (5): 1725-1738	28	37	34	49
1726	18963 Sahara N, Maeda S, Murayama M, Suzuki T, Dohmae N, et al. Assembly of two distinct dimers and higher-order oligomers from full- length tau EUROPEAN JOURNAL OF NEUROSCIENCE. 2007 MAY; 25 (10): 3020-3029	12	16	34	38
1727	19643 Forman MS, Trojanowski JQ, Lee VMY TDP-43: a novel neurodegenerative proteinopathy CURRENT OPINION IN NEUROBIOLOGY. 2007 OCT; 17 (5): 548-555	48	48	34	49
1728	19706 Bilen J, Bonini NM Genome-wide screen for modifiers of ataxin-3 neurodegeneration in drosophila PLOS GENETICS. 2007 OCT; 3 (10): 1950-1964	16	35	34	63
1729	20250 Willis GL Parkinson's Disease as a Neuroendocrine Disorder of Circadian Function: Dopamine-Melatonin Imbalance and the Visual System in the Genesis and Progression of the Degenerative Process REVIEWS IN THE NEUROSCIENCES. 2008; 19 (4-5): 245-316	0	5	34	722
1730	20385 Shacka JJ, Roth KA, Zhang JH The autophagy-lysosomal degradation pathway: role in neurodegenerative disease and therapy FRONTIERS IN BIOSCIENCE. 2008 JAN 1; 13: 718-736	5	24	34	182
#	Date / Author / Journal	LCS	GCS	LCR	CR
1731	20556 Cavalli A, Bolognesi ML, Minarini A, Rosini M, Tumiatti V, et al. Multi-target-directed ligands to combat neurodegenerative diseases JOURNAL OF MEDICINAL CHEMISTRY. 2008 FEB 14; 51 (3): 347-372	10	91	34	241
1732	20803 Hubinger G, Geis S, LeCorre S, Muhlbacher S, Gordon S, et al. Inhibition of PHF-like tau hyperphosphorylation in SH-SY5Y cells and rat brain slices by K252a JOURNAL OF ALZHEIMERS DISEASE. 2008 APR; 13 (3): 281-294	1	2	34	46
1733	20981 Li XA, Li Xing-An Zhang YJ, Zhang Ying-Jiu Chang M, Chang Ming Wang DP, Wang Dan-Ping Liu T, et al. Dysfunction of proteasome and formation of Lewy body in sporadic Parkinson's disease PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS. 2008 MAY; 35 (5): 502-511	0	1	34	69
1734	21136 Hasegawa T, Treis A, Patenge N, Fiesel FC, Springer W, et al. Parkin protects against tyrosinase-mediated dopamine neurotoxicity by suppressing stress-activated protein kinase pathways JOURNAL OF NEUROCHEMISTRY. 2008 JUN; 105 (5): 1700-1715	8	20	34	67
1735	21293 Corsetti V, Amadoro G, Gentile A, Capsoni S, Ciotti MT, et al. Identification of a caspase-derived N-terminal tau fragment in cellular and animal Alzheimer's disease models MOLECULAR AND CELLULAR NEUROSCIENCE. 2008 JUL; 38 (3): 381-392	9	13	34	80
1736	21315 Bateman RJ, Klunk WE Measuring target effect of proposed disease-modifying therapies in Alzheimer's disease NEUROTHERAPEUTICS. 2008 JUL; 5 (3): 381-390	0	3	34	103
1737	21391 Mori F, Tanji K, Zhang HX, Nishihira Y, Tan CF, et al. Maturation process of TDP-43-positive neuronal cytoplasmic inclusions in amyotrophic lateral sclerosis with and without dementia ACTA NEUROPATHOLOGICA. 2008 AUG; 116 (2): 193-203	20	20	34	40
1738	21782 Seelaar H, Kamphorst W, Rosso SM, Azmani A, Masdjedi R, et al. Distinct genetic forms of frontotemporal dementia NEUROLOGY. 2008 OCT 14; 71 (16): 1220-1226	16	18	34	44
1739	21890 Neumann M, Kretzschmar HA Molecular neuropathology of Non-Alzheimer dementia PATHOLOGE. 2008 NOV; 29 (6): 434-441	0	0	34	38
1740	22371 Howlett DR, Richardson JC The pathology of APP transgenic mice: a model of Alzheimer's disease or simply overexpression of APP? HISTOLOGY AND HISTOPATHOLOGY. 2009 JAN; 24 (1): 83-100	6	12	34	172
#	Date / Author / Journal	LCS	GCS	LCR	CR
1741	22773 Yonetani M, Nonaka T, Masuda M, Inukai Y, Oikawa T, et al. Conversion of Wild-type alpha-Synuclein into Mutant-type Fibrils and Its Propagation in the Presence of A30P Mutant JOURNAL OF BIOLOGICAL CHEMISTRY. 2009 MAR 20; 284 (12): 7940-7950	5	5	34	49
1742	23011 Perreault S, Bousquet O, Lauzon M, Paiement J, Leclerc N Increased Association Between Rough Endoplasmic Reticulum Membranes and Mitochondria in Transgenic Mice That Express P301 L Tau JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2009 MAY; 68 (5): 503-514	0	3	34	70
1743	23056 Falzone TL, Stokin GB, Lillo C, Rodrigues EM, Westerman EL, et al. Axonal Stress Kinase Activation and Tau Misbehavior Induced by Kinesin- 1 Transport Defects JOURNAL OF NEUROSCIENCE. 2009 MAY 6; 29 (18): 5758-5767	6	9	34	55
1744	23573 Crowe A, Huang WW, Ballatore C, Johnson RL, Hogan AML, et al. Identification of Aminothienopyridazine Inhibitors of Tau Assembly by Quantitative High-Throughput Screening BIOCHEMISTRY. 2009 AUG 18; 48 (32): 7732-7745	17	17	34	61
1745	23644 Duka T, Duka V, Joyce JN, Sidhu A alpha-Synuclein contributes to GSK-3 beta-catalyzed Tau phosphorylation in Parkinson's disease models FASEB JOURNAL. 2009 SEP; 23 (9): 2820-2830	7	11	34	59
1746	23854 Vogel J, Anand VS, Ludwig B, Nawoschik S, Dunlop J, et al. The JNK pathway amplifies and drives subcellular changes in tau phosphorylation NEUROPHARMACOLOGY. 2009 OCT-NOV; 57 (5-6): 539-550	0	3	34	57
1747	24194 Iranzo A, Santamaria J, Tolosa E The clinical and pathophysiological relevance of REM sleep behavior disorder in neurodegenerative diseases SLEEP MEDICINE REVIEWS. 2009 DEC; 13 (6): 385-401	3	15	34	200
1748	24347 Murphy MP, LeVine H Alzheimer's Disease and the Amyloid-beta Peptide JOURNAL OF ALZHEIMERS DISEASE. 2010; 19 (1): 311-323	1	3	34	131
1749	24352 Kim W, Lee S, Jung C, Ahmed A, Lee G, et al. Interneuronal Transfer of Human Tau Between Lamprey Central Neurons in situ JOURNAL OF ALZHEIMERS DISEASE. 2010; 19 (2): 647-664	1	2	34	54
1750	25023 Braun RJ, Buttner S, Ring J, Kroemer G, Madeo F Nervous yeast: modeling neurotoxic cell death TRENDS IN BIOCHEMICAL SCIENCES. 2010 MAR; 35 (3): 135-144	0	4	34	86
#	Date / Author / Journal	LCS	GCS	LCR	CR
1751	25200 Moloney A, Sattelle DB, Lomas DA, Crowther DC Alzheimer's disease: insights from Drosophila melanogaster models TRENDS IN BIOCHEMICAL SCIENCES. 2010 APR; 35 (4): 228-235	1	2	34	95
1752	25274 Aarsland D, Kurz MW The Epidemiology of Dementia Associated with Parkinson's Disease BRAIN PATHOLOGY. 2010 MAY; 20 (3): 633-639	0	1	34	82
1753	25339 Al-Wandi A, Ninkina N, Millership S, Williamson SJM, Jones PA, et al. Absence of alpha-synuclein affects dopamine metabolism and synaptic markers in the striatum of aging mice NEUROBIOLOGY OF AGING. 2010 MAY; 31 (5): 796-804	6	8	34	50
1754	25415 Beach TG, Adler CH, Sue LI, Vedders L, Lue L, et al. Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders ACTA NEUROPATHOLOGICA. 2010 JUN; 119 (6): 689-702	4	4	34	82
1755	25693 Kim KS, Park JY, Jou I, Park SM Regulation of Weibel-Palade Body Exocytosis by alpha-Synuclein in Endothelial Cells JOURNAL OF BIOLOGICAL CHEMISTRY. 2010 JUL 9; 285 (28): 21416-21425	0	0	34	59
1756	25980 Esposito E, Cuzzocrea S New Therapeutic Strategy for Parkinson's and Alzheimer's Disease CURRENT MEDICINAL CHEMISTRY. 2010 SEP; 17 (25): 2764-2774	0	0	34	140
1757	26014 Vitte J, Traver S, De Paula AM, Lesage S, Rovelli G, et al. Leucine-Rich Repeat Kinase 2 Is Associated With the Endoplasmic Reticulum in Dopaminergic Neurons and Accumulates in the Core of Lewy Bodies in Parkinson Disease JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2010 SEP; 69 (9): 959-972	1	1	34	68
1758	26108 De Genst EJ, Guilliams T, Wellens J, O'Day EM, Waudby CA, et al. Structure and Properties of a Complex of alpha-Synuclein and a Single- Domain Camelid Antibody JOURNAL OF MOLECULAR BIOLOGY. 2010 SEP 17; 402 (2): 326-343	0	0	34	76
1759	26160 Yagi H, Takeuchi H, Ogawa S, Ito N, Sakane I, et al. Isolation of short peptide fragments from alpha-synuclein fibril core identifies a residue important for fibril nucleation: A possible implication for diagnostic applications BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS. 2010 OCT; 1804 (10): 2077-2087	0	0	34	68
1760	26337 Bueler H Mitochondrial dynamics, cell death and the pathogenesis of Parkinson's disease APOPTOSIS. 2010 NOV; 15 (11): 1336-1353	0	3	34	225
#	Date / Author / Journal	LCS	GCS	LCR	CR
1761	26413 Schneider A, Falkai P, Papassotiropoulos A Molecular principles of tau-induced toxicity. New experimental therapy strategies for treatment of Alzheimer's disease NERVENARZT. 2010 NOV; 81 (11): 1289-+	0	0	34	52
1762	27038 Vemuri P, Simon G, Kantarci K, Whitwell JL, Senjem ML, et al. Antemortem differential diagnosis of dementia pathology using structural MRI: Differential-STAND NEUROIMAGE. 2011 MAR 15; 55 (2): 522-531	0	0	34	72
1763	1298 WIEDENMANN B, HUTTNER WB SYNAPTOPHYSIN AND CHROMOGRANINS SECRETOGRANINS - WIDESPREAD CONSTITUENTS OF DISTINCT TYPES OF NEURO-ENDOCRINE VESICLES AND NEW TOOLS IN TUMOR-DIAGNOSIS VIRCHOWS ARCHIV B-CELL PATHOLOGY INCLUDING MOLECULAR PATHOLOGY. 1989; 58 (2): 95-121	27	260	33	197
1764	2352 BALEYDIER C, MOREL A SEGREGATED THALAMOCORTICAL PATHWAYS TO INFERIOR PARIETAL AND INFEROTEMPORAL CORTEX IN MACAQUE MONKEY VISUAL NEUROSCIENCE. 1992 MAY; 8 (5): 391-405	18	49	33	78
1765	2918 CUSICK CG, SCRIPTER JL, DARENSBOURG JG, WEBER JT CHEMOARCHITECTONIC SUBDIVISIONS OF THE VISUAL PULVINAR IN MONKEYS AND THEIR CONNECTIONAL RELATIONS WITH THE MIDDLE TEMPORAL AND ROSTRAL DORSOLATERAL VISUAL AREAS, MT AND DLR JOURNAL OF COMPARATIVE NEUROLOGY. 1993 OCT 1; 336 (1): 1-30	16	66	33	97
1766	2953 GOEDERT M TAU-PROTEIN AND THE NEUROFIBRILLARY PATHOLOGY OF ALZHEIMERS-DISEASE TRENDS IN NEUROSCIENCES. 1993 NOV; 16 (11): 460-465	247	397	33	64
1767	3144 ROSA P, GERDES HH THE GRANIN PROTEIN FAMILY - MARKERS FOR NEUROENDOCRINE CELLS AND TOOLS FOR THE DIAGNOSIS OF NEUROENDOCRINE TUMORS JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION. 1994 MAR; 17 (3): 207-225	5	97	33	188
1768	4155 Mandelkow EM, Schweers O, Drewes G, Biernat J, Gustke N, et al. Structure, microtubule interactions, and phosphorylation of tau protein NEUROBIOLOGY OF ALZHEIMER'S DISEASE. 1996; 777: 96-106	24	52	33	51
1769	4345 Shea TB, Spencer MJ, Beermann ML, Cressman CM, Nixon RA Calcium influx into human neuroblastoma cells induces ALZ-50 immunoreactivity: Involvement of calpain-mediated hydrolysis of protein kinase C JOURNAL OF NEUROCHEMISTRY. 1996 APR; 66 (4): 1539-1549	26	54	33	85
1770	5349 Giannakopoulos P, Hof PR, Michel JP, Guimon J, Bouras C Cerebral cortex pathology in aging and Alzheimer's disease: a quantitative survey of large hospital-based geriatric and psychiatric cohorts BRAIN RESEARCH REVIEWS. 1997 OCT; 25 (2): 217-245	26	87	33	231
#	Date / Author / Journal	LCS	GCS	LCR	CR
1771	6116 Pallares-Trujillo J, Lopez-Soriano FJ, Argiles JM The involvement of the ubiquitin system in Alzheimer's disease (Review) INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE. 1998 JUL; 2 (1): 3-15	4	11	33	156
1772	6961 Paudel HK, Li W Heparin-induced conformational change in microtubule-associated protein tau as detected by chemical cross-linking and phosphopeptide mapping JOURNAL OF BIOLOGICAL CHEMISTRY. 1999 MAR 19; 274 (12): 8029-8038	13	28	33	45
1773	7001 Mirra SS, Murrell JR, Gearing M, Spillantini MG, Goedert M, et al. Tau pathology in a family with dementia and a P301L mutation in tau JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 1999 APR; 58 (4): 335-345	103	102	33	62
1774	7014 Storey E, Cappai R The amyloid precursor protein of Alzheimer's disease and the A beta peptide NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. 1999 APR; 25 (2): 81-97	21	74	33	202
1775	7107 Goedert M, Jakes R, Crowther RA Effects of frontotemporal dementia FTDP-17 mutations on heparin-induced assembly of tau filaments FEBS LETTERS. 1999 MAY 7; 450 (3): 306-311	135	139	33	45
1776	7615 Ishihara T, Hong M, Zhang B, Nakagawa Y, Lee MK, et al. Age-dependent emergence and progression of a tauopathy in transgenic mice overexpressing the shortest human tau isoform NEURON. 1999 NOV; 24 (3): 751-762	283	283	33	47
1777	7674 Laurer HL, McIntosh TK Experimental models of brain trauma CURRENT OPINION IN NEUROLOGY. 1999 DEC; 12 (6): 715-721	27	53	33	118
1778	7948 Schultz C, Dehghani F, Hubbard GB, Thal DR, Struckhoff G, et al. Filamentous tau pathology in nerve cells, astrocytes, and oligodendrocytes of aged baboons JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2000 JAN; 59 (1): 39-52	18	26	33	67
1779	8487 Ackerley S, Grierson AJ, Brownlees J, Thornhill P, Anderton BH, et al. Glutamate slows axonal transport of neurofilaments in transfected neurons JOURNAL OF CELL BIOLOGY. 2000 JUL 10; 150 (1): 165-175	41	78	33	90
1780	8608 Ishizawa K, Ksiezak-Reding H, Davies P, Delacourte A, Tiseo P, et al. A double-labeling immunohistochemical study of tau exon 10 in Alzheimer's disease, progressive supranuclear palsy and Pick's disease ACTA NEUROPATHOLOGICA. 2000 SEP; 100 (3): 235-244	23	25	33	60
#	Date / Author / Journal	LCS	GCS	LCR	CR
1781	8613 Bennecib M, Gong CX, Wegiel J, Lee MH, Grundke-Iqbal I, et al. Inhibition of protein phosphatases and regulation of tau phosphorylation in rat brain ALZHEIMERS REPORTS. 2000 SEP-DEC; 3 (5-6): 295-304	4	5	33	44
1782	8617 Mulder C, Scheltens P, Visser JJ, van Kamp GJ, Schutgens RBH Genetic and biochemical markers for Alzheimer's disease: recent developments ANNALS OF CLINICAL BIOCHEMISTRY. 2000 SEP; 37: 593-607	9	17	33	138
1783	8779 Duda JE, Giasson BI, Chen QP, Gur TL, Hurtig HI, et al. Widespread nitration of pathological inclusions in neurodegenerative synucleinopathies AMERICAN JOURNAL OF PATHOLOGY. 2000 NOV; 157 (5): 1439-1445	119	119	33	58
1784	9310 Vaughan JR, Davis MB, Wood NW Genetics of Parkinsonism: a review ANNALS OF HUMAN GENETICS. 2001 MAR; 65: 111-126	9	38	33	119
1785	10833 Miake H, Mizusawa H, Iwatsubo T, Hasegawa M Biochemical characterization of the core structure of alpha-synuclein filaments JOURNAL OF BIOLOGICAL CHEMISTRY. 2002 MAY 24; 277 (21): 19213-19219	72	87	33	35
1786	10846 Forman MS, Zhukareva V, Bergeron C, Chin SSM, Grossman M, et al. Signature tau neuropathology in gray and white matter of corticobasal degeneration AMERICAN JOURNAL OF PATHOLOGY. 2002 JUN; 160 (6): 2045-2053	49	49	33	58
1787	11244 Pan ZZ, Bruening W, Giasson BI, Lee VMY, Godwin AK gamma-Synuclein promotes cancer cell survival and inhibits stress- and chemotherapy drug-induced apoptosis by modulating MAPK pathways JOURNAL OF BIOLOGICAL CHEMISTRY. 2002 SEP 20; 277 (38): 35050-35060	36	53	33	65
1788	11403 DeTure M, Ko LW, Easson C, Yen SH tau assembly in inducible transfectants expressing wild-type or FTDP-17 tau AMERICAN JOURNAL OF PATHOLOGY. 2002 NOV; 161 (5): 1711-1722	33	38	33	41
1789	11555 Sahara N, Lewis J, DeTure M, McGowan E, Dickson DW, et al. Assembly of tau in transgenic animals expressing P301L tau: alteration of phosphorylation and solubility JOURNAL OF NEUROCHEMISTRY. 2002 DEC; 83 (6): 1498-1508	43	45	33	39
1790	11822 Katsetos CD, Del Valle L, Legido A, de Chadarevian JP, Perentes E, et al. On the neuronal/neuroblastic nature of medulloblastomas: a tribute to Pio del Rio Hortega and Moises Polak ACTA NEUROPATHOLOGICA. 2003 JAN; 105 (1): 1-13	7	20	33	106
#	Date / Author / Journal	LCS	GCS	LCR	CR
1791	12360 de Silva R, Lashley T, Gibb G, Hanger D, Hope A, et al. Pathological inclusion bodies in tauopathies contain distinct complements of tau with three or four microtubule-binding repeat domains as demonstrated by new specific monoclonal antibodies NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. 2003 JUN; 29 (3): 288-302	65	81	33	39
1792	12378 Tsai YC, Fishman PS, Thakor NV, Oyler GA Parkin facilitates the elimination of expanded polyglutamine proteins and leads to preservation of proteasome function JOURNAL OF BIOLOGICAL CHEMISTRY. 2003 JUN 13; 278 (24): 22044-22055	42	100	33	83
1793	12747 Lee HG, Petersen RB, Zhu XW, Honda K, Aliev G, et al. Will preventing protein aggregates live up to its promise as prophylaxis against neurodegenerative diseases? BRAIN PATHOLOGY. 2003 OCT; 13 (4): 630-638	9	16	33	120
1794	13267 Gotz ME, Double K, Gerlach M, Youdim MBH, Riederer P The relevance of iron in the pathogenesis of Parkinson's disease REDOX-ACTIVE METALS IN NEUROLOGICAL DISORDERS. 2004; 1012: 193-208	19	96	33	129
1795	13385 Hernandez F, Perez M, Lucas JJ, Mata AM, Bhat R, et al. Glycogen synthase kinase-3 plays a crucial role in tau exon 10 splicing and intranuclear distribution of SC35 - Implications for Alzheimer's disease JOURNAL OF BIOLOGICAL CHEMISTRY. 2004 JAN 30; 279 (5): 3801-3806	20	40	33	64
1796	13446 Jakel RJ, Schneider BL, Svendsen CN Using human neural stem cells to model neurological disease NATURE REVIEWS GENETICS. 2004 FEB; 5 (2): 136-U17	4	21	33	105
1797	13566 Haase C, Stieler JT, Arendt T, Holzer M Pseudophosphorylation of tau protein alters its ability for self- aggregation JOURNAL OF NEUROCHEMISTRY. 2004 MAR; 88 (6): 1509-1520	27	43	33	45
1798	13635 Santa-Maria I, Hernandez F, Martin CP, Avila J, Moreno FJ Quinones facilitate the self-assembly of the phosphorylated tubulin binding region of tau into fibrillar polymers BIOCHEMISTRY. 2004 MAR 16; 43 (10): 2888-2897	15	25	33	61
1799	13871 Moussa CEH, Wersinger C, Tomita Y, Sidhu A Differential cytotoxicity of human wild type and mutant alpha-synuclein in human neuroblastoma SH-SY5Y cells in the presence of dopamine BIOCHEMISTRY. 2004 MAY 11; 43 (18): 5539-5550	17	25	33	76
1800	13953 Ackerley S, Grierson AJ, Banner S, Perkinton MS, Brownlees J, et al. p38 alpha stress-activated protein kinase phosphorylates neurofilaments and is associated with neurofilament pathology in amyotrophic lateral sclerosis MOLECULAR AND CELLULAR NEUROSCIENCE. 2004 JUN; 26 (2): 354-364	16	35	33	69

Date / Author / Journal

LCS

GCS

LCR

1701

15345 Forman MS, Lal D, Zhang B, Dabir DV, Swanson E, et al.

Transgenic mouse model of tau pathology in astrocytes leading to nervous system degeneration

JOURNAL OF NEUROSCIENCE. 2005 APR 6; 25 (14): 3539-3550

1702

16079 Taniguchi T, Doe N, Matsuyama S, Kitamura Y, Mori H, et al.

Transgenic mice expressing mutant (N279K) human tau show mutation dependent cognitive deficits without neurofibrillary tangle formation

FEBS LETTERS. 2005 OCT 24; 579 (25): 5704-5712

1703

16290 Zhang C, Saatman KE, Royo NC, Soltesz KM, Millard M, et al.

Delayed transplantation of human neurons following brain injury in rats: A long-term graft survival and behavior study

JOURNAL OF NEUROTRAUMA. 2005 DEC; 22 (12): 1456-1474

1704

16333 Dermaut B, Kumar-Singh S, Rademakers R, Theuns J, Cruts M, et al.

Tau is central in the genetic Alzheimer-frontotemporal dementia spectrum

TRENDS IN GENETICS. 2005 DEC; 21 (12): 664-672

1705

16461 Kurz MW, Schlitter AM, Larsen JP, Ballard C, Aarsland D

Familial occurrence of dementia and parkinsonism - A systematic review

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2006; 22 (4): 288-295

1706

16887 Sarkar C, Deb P, Sharma MC

Medulloblastomas: New directions in risk stratification

NEUROLOGY INDIA. 2006 MAR; 54 (1): 16-23

130

1707

16901 Zhou WB, Zhu M, Wilson MA, Petsko GA, Fink AL

The oxidation state of DJ-1 regulates its chaperone activity toward alpha-synuclein

JOURNAL OF MOLECULAR BIOLOGY. 2006 MAR 3; 356 (4): 1036-1048

1708

16966 Chaudhuri TK, Paul S

Protein-misfolding diseases and chaperone-based therapeutic approaches

FEBS JOURNAL. 2006 APR; 273 (7): 1331-1349

145

1709

17085 Motil J, Chan WKH, Dubey M, Chaudhury P, Pimenta A, et al.

Dynein mediates retrograde neurofilament transport within axons and anterograde delivery of NFs from perikarya into axons: Regulation by multiple phosphorylation events

CELL MOTILITY AND THE CYTOSKELETON. 2006 MAY; 63 (5): 266-286

1710

17151 Jabbour-Wadih T, Alonso-Navarro H, Ayuso-Peralta L, Jimenez-Jimenez FJ

The neurochemistry and neuropharmacology of diffuse Lewy body disease

REVISTA DE NEUROLOGIA. 2006 MAY 1; 42 (9): 549-555

109

Date / Author / Journal

LCS

GCS

LCR

1711

17158 Llado A, Gaig C, Molinuevo JL

Genetics of prevalent neurodegenerative disorders

MEDICINA CLINICA. 2006 MAY 6; 126 (17): 662-670

104

1712

17295 Golovko MY, Rosenberger TA, Faergeman NJ, Feddersen S, Cole NB, et al.

Acyl-CoA synthetase activity links wild-type but not mutant alpha- synuclein to brain arachidonate metabolism

BIOCHEMISTRY. 2006 JUN 6; 45 (22): 6956-6966

1713

17551 Jellinger KA, Attems J

Does striatal pathology distinguish Parkinson disease with dementia and dementia with Lewy bodies?

ACTA NEUROPATHOLOGICA. 2006 SEP; 112 (3): 253-260

1714

17661 Vandebroek T, Terwel D, Vanhelmont T, Gysemans M, Van Haesendonck C, et al.

Microtubule binding and clustering of human Tau-4R and Tau-P301L proteins isolated from yeast deficient in orthologues of glycogen synthase kinase-3 beta or cdk5

JOURNAL OF BIOLOGICAL CHEMISTRY. 2006 SEP 1; 281 (35): 25388-25397

1715

17673 Karsten SL, Sang TK, Gehman LT, Chatterjee S, Liu JK, et al.

A genomic screen for modifiers of tauopathy identifies puromycin- sensitive aminopeptidase as an inhibitor of tau-induced neurodegeneration

NEURON. 2006 SEP 7; 51 (5): 549-560

1716

17712 Murakami T, Paitel E, Kawarabayashi T, Ikeda M, Chishti MA, et al.

Cortical neuronal and glial pathology in TgTau(P301L) transgenic mice - Neuronal degeneration, memory disturbance, and phenotypic variation

AMERICAN JOURNAL OF PATHOLOGY. 2006 OCT; 169 (4): 1365-1375

1717

17926 Caselli RJ, Beach TG, Yaari R, Reiman EM

Alzheimer's disease a century later

JOURNAL OF CLINICAL PSYCHIATRY. 2006 NOV; 67 (11): 1784-1800

199

1718

17959 Colapinto M, Mila S, Giraudo S, Stefanazzi P, Molteni M, et al.

alpha-synuclein protects SH-SY5Y cells from dopamine toxicity

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2006 NOV 3; 349 (4): 1294-1300

1719

18231 Krewski D, Yokel RA, Nieboer E, Borchelt D, Cohen J, et al.

Human health risk assessment for aluminium, aluminium oxide, and aluminium hydroxide

JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART B-CRITICAL REVIEWS. 2007; 10: 1-269

1515

1720

18260 Schmidt E, Seifert M, Baumeister R

Caenorhabditis elegans as a model system for Parkinson's disease

NEURODEGENERATIVE DISEASES. 2007; 4 (2-3): 199-217

110

Date / Author / Journal

1721

The pathology of the hippocampus in schizophrenia

ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA. 2007; 107 (12): 103-114

166

1722

18365 Frid P, Anisimov SV, Popovic N

Congo red and protein aggregation in neurodegenerative diseases

BRAIN RESEARCH REVIEWS. 2007 JAN; 53 (1): 135-160

214

1723

18530 Liu LL, Franz KJ

Phosphorylation-dependent metal binding by alpha-synuclein peptide fragments

JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY. 2007 FEB; 12 (2): 234-247

1724

18831 Golovko MY, Rosenberger TA, Feddersen S, Faergeman NJ, Murphy EJ

alpha-Synuclein gene ablation increases docosahexaenoic acid incorporation and turnover in brain phospholipids

JOURNAL OF NEUROCHEMISTRY. 2007 APR; 101 (1): 201-211

1725

18929 Dufty BM, Warner LR, Hou ST, Jiang SX, Gomez-Isla T, et al.

Calpain-cleavage of alpha-synuclein - Connecting proteolytic processing to disease-linked aggregation

AMERICAN JOURNAL OF PATHOLOGY. 2007 MAY; 170 (5): 1725-1738

1726

18963 Sahara N, Maeda S, Murayama M, Suzuki T, Dohmae N, et al.

Assembly of two distinct dimers and higher-order oligomers from full- length tau

EUROPEAN JOURNAL OF NEUROSCIENCE. 2007 MAY; 25 (10): 3020-3029

1727

19643 Forman MS, Trojanowski JQ, Lee VMY

TDP-43: a novel neurodegenerative proteinopathy

CURRENT OPINION IN NEUROBIOLOGY. 2007 OCT; 17 (5): 548-555

1728

19706 Bilen J, Bonini NM

Genome-wide screen for modifiers of ataxin-3 neurodegeneration in drosophila

PLOS GENETICS. 2007 OCT; 3 (10): 1950-1964

1729

20250 Willis GL

Parkinson's Disease as a Neuroendocrine Disorder of Circadian Function: Dopamine-Melatonin Imbalance and the Visual System in the Genesis and Progression of the Degenerative Process

REVIEWS IN THE NEUROSCIENCES. 2008; 19 (4-5): 245-316

722

1730

20385 Shacka JJ, Roth KA, Zhang JH

The autophagy-lysosomal degradation pathway: role in neurodegenerative disease and therapy

FRONTIERS IN BIOSCIENCE. 2008 JAN 1; 13: 718-736

182

Date / Author / Journal

LCS

GCS

LCR

1731

20556 Cavalli A, Bolognesi ML, Minarini A, Rosini M, Tumiatti V, et al.

Multi-target-directed ligands to combat neurodegenerative diseases

JOURNAL OF MEDICINAL CHEMISTRY. 2008 FEB 14; 51 (3): 347-372

241

1732

20803 Hubinger G, Geis S, LeCorre S, Muhlbacher S, Gordon S, et al.

Inhibition of PHF-like tau hyperphosphorylation in SH-SY5Y cells and rat brain slices by K252a

JOURNAL OF ALZHEIMERS DISEASE. 2008 APR; 13 (3): 281-294

1733

20981 Li XA, Li Xing-An Zhang YJ, Zhang Ying-Jiu Chang M, Chang Ming Wang DP, Wang Dan-Ping Liu T, et al.

Dysfunction of proteasome and formation of Lewy body in sporadic Parkinson's disease

PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS. 2008 MAY; 35 (5): 502-511

1734

21136 Hasegawa T, Treis A, Patenge N, Fiesel FC, Springer W, et al.

Parkin protects against tyrosinase-mediated dopamine neurotoxicity by suppressing stress-activated protein kinase pathways

JOURNAL OF NEUROCHEMISTRY. 2008 JUN; 105 (5): 1700-1715

1735

21293 Corsetti V, Amadoro G, Gentile A, Capsoni S, Ciotti MT, et al.

Identification of a caspase-derived N-terminal tau fragment in cellular and animal Alzheimer's disease models

MOLECULAR AND CELLULAR NEUROSCIENCE. 2008 JUL; 38 (3): 381-392

1736

21315 Bateman RJ, Klunk WE

Measuring target effect of proposed disease-modifying therapies in Alzheimer's disease

NEUROTHERAPEUTICS. 2008 JUL; 5 (3): 381-390

103

1737

21391 Mori F, Tanji K, Zhang HX, Nishihira Y, Tan CF, et al.

Maturation process of TDP-43-positive neuronal cytoplasmic inclusions in amyotrophic lateral sclerosis with and without dementia

ACTA NEUROPATHOLOGICA. 2008 AUG; 116 (2): 193-203

1738

21782 Seelaar H, Kamphorst W, Rosso SM, Azmani A, Masdjedi R, et al.

Distinct genetic forms of frontotemporal dementia

NEUROLOGY. 2008 OCT 14; 71 (16): 1220-1226

1739

21890 Neumann M, Kretzschmar HA

Molecular neuropathology of Non-Alzheimer dementia

PATHOLOGE. 2008 NOV; 29 (6): 434-441

1740

22371 Howlett DR, Richardson JC

The pathology of APP transgenic mice: a model of Alzheimer's disease or simply overexpression of APP?

HISTOLOGY AND HISTOPATHOLOGY. 2009 JAN; 24 (1): 83-100

172

Date / Author / Journal

LCS

GCS

LCR

1741

22773 Yonetani M, Nonaka T, Masuda M, Inukai Y, Oikawa T, et al.

Conversion of Wild-type alpha-Synuclein into Mutant-type Fibrils and Its Propagation in the Presence of A30P Mutant

JOURNAL OF BIOLOGICAL CHEMISTRY. 2009 MAR 20; 284 (12): 7940-7950

1742

23011 Perreault S, Bousquet O, Lauzon M, Paiement J, Leclerc N

Increased Association Between Rough Endoplasmic Reticulum Membranes and Mitochondria in Transgenic Mice That Express P301 L Tau

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2009 MAY; 68 (5): 503-514

1743

23056 Falzone TL, Stokin GB, Lillo C, Rodrigues EM, Westerman EL, et al.

Axonal Stress Kinase Activation and Tau Misbehavior Induced by Kinesin- 1 Transport Defects

JOURNAL OF NEUROSCIENCE. 2009 MAY 6; 29 (18): 5758-5767

1744

23573 Crowe A, Huang WW, Ballatore C, Johnson RL, Hogan AML, et al.

Identification of Aminothienopyridazine Inhibitors of Tau Assembly by Quantitative High-Throughput Screening

BIOCHEMISTRY. 2009 AUG 18; 48 (32): 7732-7745

1745

23644 Duka T, Duka V, Joyce JN, Sidhu A

alpha-Synuclein contributes to GSK-3 beta-catalyzed Tau phosphorylation in Parkinson's disease models

FASEB JOURNAL. 2009 SEP; 23 (9): 2820-2830

1746

23854 Vogel J, Anand VS, Ludwig B, Nawoschik S, Dunlop J, et al.

The JNK pathway amplifies and drives subcellular changes in tau phosphorylation

NEUROPHARMACOLOGY. 2009 OCT-NOV; 57 (5-6): 539-550

1747

24194 Iranzo A, Santamaria J, Tolosa E

The clinical and pathophysiological relevance of REM sleep behavior disorder in neurodegenerative diseases

SLEEP MEDICINE REVIEWS. 2009 DEC; 13 (6): 385-401

200

1748

24347 Murphy MP, LeVine H

Alzheimer's Disease and the Amyloid-beta Peptide

JOURNAL OF ALZHEIMERS DISEASE. 2010; 19 (1): 311-323

131

1749

24352 Kim W, Lee S, Jung C, Ahmed A, Lee G, et al.

Interneuronal Transfer of Human Tau Between Lamprey Central Neurons in situ

JOURNAL OF ALZHEIMERS DISEASE. 2010; 19 (2): 647-664

1750

25023 Braun RJ, Buttner S, Ring J, Kroemer G, Madeo F

Nervous yeast: modeling neurotoxic cell death

TRENDS IN BIOCHEMICAL SCIENCES. 2010 MAR; 35 (3): 135-144

Date / Author / Journal

LCS

GCS

LCR

1751

25200 Moloney A, Sattelle DB, Lomas DA, Crowther DC

Alzheimer's disease: insights from Drosophila melanogaster models

TRENDS IN BIOCHEMICAL SCIENCES. 2010 APR; 35 (4): 228-235

1752

25274 Aarsland D, Kurz MW

The Epidemiology of Dementia Associated with Parkinson's Disease

BRAIN PATHOLOGY. 2010 MAY; 20 (3): 633-639

1753

25339 Al-Wandi A, Ninkina N, Millership S, Williamson SJM, Jones PA, et al.

Absence of alpha-synuclein affects dopamine metabolism and synaptic markers in the striatum of aging mice

NEUROBIOLOGY OF AGING. 2010 MAY; 31 (5): 796-804

1754

25415 Beach TG, Adler CH, Sue LI, Vedders L, Lue L, et al.

Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders

ACTA NEUROPATHOLOGICA. 2010 JUN; 119 (6): 689-702

1755

25693 Kim KS, Park JY, Jou I, Park SM

Regulation of Weibel-Palade Body Exocytosis by alpha-Synuclein in Endothelial Cells

JOURNAL OF BIOLOGICAL CHEMISTRY. 2010 JUL 9; 285 (28): 21416-21425

1756

25980 Esposito E, Cuzzocrea S

New Therapeutic Strategy for Parkinson's and Alzheimer's Disease

CURRENT MEDICINAL CHEMISTRY. 2010 SEP; 17 (25): 2764-2774

140

1757

26014 Vitte J, Traver S, De Paula AM, Lesage S, Rovelli G, et al.

Leucine-Rich Repeat Kinase 2 Is Associated With the Endoplasmic Reticulum in Dopaminergic Neurons and Accumulates in the Core of Lewy Bodies in Parkinson Disease

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2010 SEP; 69 (9): 959-972

1758

26108 De Genst EJ, Guilliams T, Wellens J, O'Day EM, Waudby CA, et al.

Structure and Properties of a Complex of alpha-Synuclein and a Single- Domain Camelid Antibody

JOURNAL OF MOLECULAR BIOLOGY. 2010 SEP 17; 402 (2): 326-343

1759

26160 Yagi H, Takeuchi H, Ogawa S, Ito N, Sakane I, et al.

Isolation of short peptide fragments from alpha-synuclein fibril core identifies a residue important for fibril nucleation: A possible implication for diagnostic applications

BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS. 2010 OCT; 1804 (10): 2077-2087

1760

26337 Bueler H

Mitochondrial dynamics, cell death and the pathogenesis of Parkinson's disease

APOPTOSIS. 2010 NOV; 15 (11): 1336-1353

225

Date / Author / Journal

LCS

GCS

LCR

1761

26413 Schneider A, Falkai P, Papassotiropoulos A

Molecular principles of tau-induced toxicity. New experimental therapy strategies for treatment of Alzheimer's disease

NERVENARZT. 2010 NOV; 81 (11): 1289-+

1762

27038 Vemuri P, Simon G, Kantarci K, Whitwell JL, Senjem ML, et al.

Antemortem differential diagnosis of dementia pathology using structural MRI: Differential-STAND

NEUROIMAGE. 2011 MAR 15; 55 (2): 522-531

1763

1298 WIEDENMANN B, HUTTNER WB

SYNAPTOPHYSIN AND CHROMOGRANINS SECRETOGRANINS - WIDESPREAD CONSTITUENTS OF DISTINCT TYPES OF NEURO-ENDOCRINE VESICLES AND NEW TOOLS IN TUMOR-DIAGNOSIS

VIRCHOWS ARCHIV B-CELL PATHOLOGY INCLUDING MOLECULAR PATHOLOGY. 1989; 58 (2): 95-121

260

197

1764

2352 BALEYDIER C, MOREL A

SEGREGATED THALAMOCORTICAL PATHWAYS TO INFERIOR PARIETAL AND INFEROTEMPORAL CORTEX IN MACAQUE MONKEY

VISUAL NEUROSCIENCE. 1992 MAY; 8 (5): 391-405

1765

2918 CUSICK CG, SCRIPTER JL, DARENSBOURG JG, WEBER JT

CHEMOARCHITECTONIC SUBDIVISIONS OF THE VISUAL PULVINAR IN MONKEYS AND THEIR CONNECTIONAL RELATIONS WITH THE MIDDLE TEMPORAL AND ROSTRAL DORSOLATERAL VISUAL AREAS, MT AND DLR

JOURNAL OF COMPARATIVE NEUROLOGY. 1993 OCT 1; 336 (1): 1-30

1766

2953 GOEDERT M

TAU-PROTEIN AND THE NEUROFIBRILLARY PATHOLOGY OF ALZHEIMERS-DISEASE

TRENDS IN NEUROSCIENCES. 1993 NOV; 16 (11): 460-465

247

397

1767

3144 ROSA P, GERDES HH

THE GRANIN PROTEIN FAMILY - MARKERS FOR NEUROENDOCRINE CELLS AND TOOLS FOR THE DIAGNOSIS OF NEUROENDOCRINE TUMORS

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION. 1994 MAR; 17 (3): 207-225

188

1768

4155 Mandelkow EM, Schweers O, Drewes G, Biernat J, Gustke N, et al.

Structure, microtubule interactions, and phosphorylation of tau protein

NEUROBIOLOGY OF ALZHEIMER'S DISEASE. 1996; 777: 96-106

1769

4345 Shea TB, Spencer MJ, Beermann ML, Cressman CM, Nixon RA

Calcium influx into human neuroblastoma cells induces ALZ-50 immunoreactivity: Involvement of calpain-mediated hydrolysis of protein kinase C

JOURNAL OF NEUROCHEMISTRY. 1996 APR; 66 (4): 1539-1549

1770

5349 Giannakopoulos P, Hof PR, Michel JP, Guimon J, Bouras C

Cerebral cortex pathology in aging and Alzheimer's disease: a quantitative survey of large hospital-based geriatric and psychiatric cohorts

BRAIN RESEARCH REVIEWS. 1997 OCT; 25 (2): 217-245

231

Date / Author / Journal

LCS

GCS

LCR

1771

6116 Pallares-Trujillo J, Lopez-Soriano FJ, Argiles JM

The involvement of the ubiquitin system in Alzheimer's disease (Review)

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE. 1998 JUL; 2 (1): 3-15

156

1772

6961 Paudel HK, Li W

Heparin-induced conformational change in microtubule-associated protein tau as detected by chemical cross-linking and phosphopeptide mapping

JOURNAL OF BIOLOGICAL CHEMISTRY. 1999 MAR 19; 274 (12): 8029-8038

1773

7001 Mirra SS, Murrell JR, Gearing M, Spillantini MG, Goedert M, et al.

Tau pathology in a family with dementia and a P301L mutation in tau

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 1999 APR; 58 (4): 335-345

103

102

1774

7014 Storey E, Cappai R

The amyloid precursor protein of Alzheimer's disease and the A beta peptide

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. 1999 APR; 25 (2): 81-97

202

1775

7107 Goedert M, Jakes R, Crowther RA

Effects of frontotemporal dementia FTDP-17 mutations on heparin-induced assembly of tau filaments

FEBS LETTERS. 1999 MAY 7; 450 (3): 306-311

135

139

1776

7615 Ishihara T, Hong M, Zhang B, Nakagawa Y, Lee MK, et al.

Age-dependent emergence and progression of a tauopathy in transgenic mice overexpressing the shortest human tau isoform

NEURON. 1999 NOV; 24 (3): 751-762

283

1777

7674 Laurer HL, McIntosh TK

Experimental models of brain trauma

CURRENT OPINION IN NEUROLOGY. 1999 DEC; 12 (6): 715-721

118

1778

7948 Schultz C, Dehghani F, Hubbard GB, Thal DR, Struckhoff G, et al.

Filamentous tau pathology in nerve cells, astrocytes, and oligodendrocytes of aged baboons

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2000 JAN; 59 (1): 39-52

1779

8487 Ackerley S, Grierson AJ, Brownlees J, Thornhill P, Anderton BH, et al.

Glutamate slows axonal transport of neurofilaments in transfected neurons

JOURNAL OF CELL BIOLOGY. 2000 JUL 10; 150 (1): 165-175

1780

8608 Ishizawa K, Ksiezak-Reding H, Davies P, Delacourte A, Tiseo P, et al.

A double-labeling immunohistochemical study of tau exon 10 in Alzheimer's disease, progressive supranuclear palsy and Pick's disease

ACTA NEUROPATHOLOGICA. 2000 SEP; 100 (3): 235-244

Date / Author / Journal

LCS

GCS

LCR

1781

8613 Bennecib M, Gong CX, Wegiel J, Lee MH, Grundke-Iqbal I, et al.

Inhibition of protein phosphatases and regulation of tau phosphorylation in rat brain

ALZHEIMERS REPORTS. 2000 SEP-DEC; 3 (5-6): 295-304

1782

8617 Mulder C, Scheltens P, Visser JJ, van Kamp GJ, Schutgens RBH

Genetic and biochemical markers for Alzheimer's disease: recent developments

ANNALS OF CLINICAL BIOCHEMISTRY. 2000 SEP; 37: 593-607

138

1783

8779 Duda JE, Giasson BI, Chen QP, Gur TL, Hurtig HI, et al.

Widespread nitration of pathological inclusions in neurodegenerative synucleinopathies

AMERICAN JOURNAL OF PATHOLOGY. 2000 NOV; 157 (5): 1439-1445

119

1784

9310 Vaughan JR, Davis MB, Wood NW

Genetics of Parkinsonism: a review

ANNALS OF HUMAN GENETICS. 2001 MAR; 65: 111-126

119

1785

10833 Miake H, Mizusawa H, Iwatsubo T, Hasegawa M

Biochemical characterization of the core structure of alpha-synuclein filaments

JOURNAL OF BIOLOGICAL CHEMISTRY. 2002 MAY 24; 277 (21): 19213-19219

1786

10846 Forman MS, Zhukareva V, Bergeron C, Chin SSM, Grossman M, et al.

Signature tau neuropathology in gray and white matter of corticobasal degeneration

AMERICAN JOURNAL OF PATHOLOGY. 2002 JUN; 160 (6): 2045-2053

1787

11244 Pan ZZ, Bruening W, Giasson BI, Lee VMY, Godwin AK

gamma-Synuclein promotes cancer cell survival and inhibits stress- and chemotherapy drug-induced apoptosis by modulating MAPK pathways

JOURNAL OF BIOLOGICAL CHEMISTRY. 2002 SEP 20; 277 (38): 35050-35060

1788

11403 DeTure M, Ko LW, Easson C, Yen SH

tau assembly in inducible transfectants expressing wild-type or FTDP-17 tau

AMERICAN JOURNAL OF PATHOLOGY. 2002 NOV; 161 (5): 1711-1722

1789

11555 Sahara N, Lewis J, DeTure M, McGowan E, Dickson DW, et al.

Assembly of tau in transgenic animals expressing P301L tau: alteration of phosphorylation and solubility

JOURNAL OF NEUROCHEMISTRY. 2002 DEC; 83 (6): 1498-1508

1790

11822 Katsetos CD, Del Valle L, Legido A, de Chadarevian JP, Perentes E, et al.

On the neuronal/neuroblastic nature of medulloblastomas: a tribute to Pio del Rio Hortega and Moises Polak

ACTA NEUROPATHOLOGICA. 2003 JAN; 105 (1): 1-13

106

Date / Author / Journal

LCS

GCS

LCR

1791

12360 de Silva R, Lashley T, Gibb G, Hanger D, Hope A, et al.

Pathological inclusion bodies in tauopathies contain distinct complements of tau with three or four microtubule-binding repeat domains as demonstrated by new specific monoclonal antibodies

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. 2003 JUN; 29 (3): 288-302

1792

12378 Tsai YC, Fishman PS, Thakor NV, Oyler GA

Parkin facilitates the elimination of expanded polyglutamine proteins and leads to preservation of proteasome function

JOURNAL OF BIOLOGICAL CHEMISTRY. 2003 JUN 13; 278 (24): 22044-22055

100

1793

12747 Lee HG, Petersen RB, Zhu XW, Honda K, Aliev G, et al.

Will preventing protein aggregates live up to its promise as prophylaxis against neurodegenerative diseases?

BRAIN PATHOLOGY. 2003 OCT; 13 (4): 630-638

120

1794

13267 Gotz ME, Double K, Gerlach M, Youdim MBH, Riederer P

The relevance of iron in the pathogenesis of Parkinson's disease

REDOX-ACTIVE METALS IN NEUROLOGICAL DISORDERS. 2004; 1012: 193-208

129

1795

13385 Hernandez F, Perez M, Lucas JJ, Mata AM, Bhat R, et al.

Glycogen synthase kinase-3 plays a crucial role in tau exon 10 splicing and intranuclear distribution of SC35 - Implications for Alzheimer's disease

JOURNAL OF BIOLOGICAL CHEMISTRY. 2004 JAN 30; 279 (5): 3801-3806

1796

13446 Jakel RJ, Schneider BL, Svendsen CN

Using human neural stem cells to model neurological disease

NATURE REVIEWS GENETICS. 2004 FEB; 5 (2): 136-U17

105

1797

13566 Haase C, Stieler JT, Arendt T, Holzer M

Pseudophosphorylation of tau protein alters its ability for self- aggregation

JOURNAL OF NEUROCHEMISTRY. 2004 MAR; 88 (6): 1509-1520

1798

13635 Santa-Maria I, Hernandez F, Martin CP, Avila J, Moreno FJ

Quinones facilitate the self-assembly of the phosphorylated tubulin binding region of tau into fibrillar polymers

BIOCHEMISTRY. 2004 MAR 16; 43 (10): 2888-2897

1799

13871 Moussa CEH, Wersinger C, Tomita Y, Sidhu A

Differential cytotoxicity of human wild type and mutant alpha-synuclein in human neuroblastoma SH-SY5Y cells in the presence of dopamine

BIOCHEMISTRY. 2004 MAY 11; 43 (18): 5539-5550

1800

13953 Ackerley S, Grierson AJ, Banner S, Perkinton MS, Brownlees J, et al.

p38 alpha stress-activated protein kinase phosphorylates neurofilaments and is associated with neurofilament pathology in amyotrophic lateral sclerosis

MOLECULAR AND CELLULAR NEUROSCIENCE. 2004 JUN; 26 (2): 354-364

Trojanowski w/citing papers Publications by JQ Trojanowski and the papers citing JQ Trojanowski	Historiographs	Glossary HistCite Guide About Grand Totals: LCS 336329, GCS 1007154, CR 1762209 Collection span: 1973 - 2011
List of All Records